{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T00:09:07Z","timestamp":1794874147861,"version":"4.9.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T00:00:00Z","timestamp":1685059200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T00:00:00Z","timestamp":1685059200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>African swine fever (ASF) is a highly fatal disease in domestic pigs caused by ASF virus (ASFV), for which there is currently no commercial vaccine available. The genome of ASFV encodes more than 150 proteins, some of which have been included in subunit vaccines but only induce limited protection against ASFV challenge.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>To enhance immune responses induced by ASFV proteins, we expressed and purified three fusion proteins with each consisting of bacterial lipoprotein OprI, 2 different ASFV proteins\/epitopes and a universal CD4<jats:sup>+<\/jats:sup> T cell epitope, namely OprI-p30-modified p54-TT, OprI-p72 epitopes-truncated pE248R-TT, and OprI-truncated CD2v-truncated pEP153R-TT. The immunostimulatory activity of these recombinant proteins was first assessed on dendritic cells. Then, humoral and cellular immunity induced by these three OprI-fused proteins cocktail formulated with ISA206 adjuvant (O-Ags-T formulation) were assessed in pigs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The OprI-fused proteins activated dendritic cells with elevated secretion of proinflammatory cytokines. Furthermore, the O-Ags-T formulation elicited a high level of antigen-specific IgG responses and interferon-\u03b3-secreting CD4<jats:sup>+<\/jats:sup> and CD8<jats:sup>+<\/jats:sup> T cells after stimulation in vitro. Importantly, the sera and peripheral blood mononuclear cells from pigs vaccinated with the O-Ags-T formulation respectively reduced ASFV infection in vitro by 82.8% and 92.6%.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our results suggest that the OprI-fused proteins cocktail formulated with ISA206 adjuvant induces robust ASFV-specific humoral and cellular immune responses in pigs. Our study provides valuable information for the further development of subunit vaccines against ASF.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12985-023-02070-7","type":"journal-article","created":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T16:01:57Z","timestamp":1685116917000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Evaluation of humoral and cellular immune responses induced by a cocktail of recombinant African swine fever virus antigens fused with OprI in domestic pigs"],"prefix":"10.1186","volume":"20","author":[{"given":"Guanglei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sicheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunyun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangqing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaxia","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjun","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiyun","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,26]]},"reference":[{"key":"2070_CR1","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.antiviral.2019.02.018","volume":"165","author":"LK Dixon","year":"2019","unstructured":"Dixon LK, Sun H, Roberts H. African swine fever. Antiviral Res. 2019;165:34\u201341.","journal-title":"Antiviral Res"},{"key":"2070_CR2","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1099\/jgv.0.001049","volume":"99","author":"C Alonso","year":"2018","unstructured":"Alonso C, Borca M, Dixon L, Revilla Y, Rodriguez F, Escribano JM, Ictv Report C. ICTV virus taxonomy profile: asfarviridae. J Gen Virol. 2018;99:613\u20134.","journal-title":"J Gen Virol"},{"key":"2070_CR3","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1146\/annurev-animal-021419-083741","volume":"8","author":"LK Dixon","year":"2020","unstructured":"Dixon LK, Stahl K, Jori F, Vial L, Pfeiffer DU. African swine fever epidemiology and control. Annu Rev Anim Biosci. 2020;8:221\u201346.","journal-title":"Annu Rev Anim Biosci"},{"key":"2070_CR4","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1111\/tbed.12700","volume":"65","author":"CJ Quembo","year":"2018","unstructured":"Quembo CJ, Jori F, Vosloo W, Heath L. Genetic characterization of African swine fever virus isolates from soft ticks at the wildlife\/domestic interface in Mozambique and identification of a novel genotype. Transbound Emerg Dis. 2018;65:420\u201331.","journal-title":"Transbound Emerg Dis"},{"key":"2070_CR5","first-page":"119","volume":"2002","author":"M Arias","year":"2022","unstructured":"Arias M, S\u00e1nchez-Vizca\u00edno JM, Morilla A, Yoon K, Zimmerman J. African swine fever. Trends Emerg Viral Infect Swine. 2022;2002:119\u201324.","journal-title":"Trends Emerg Viral Infect Swine"},{"key":"2070_CR6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40813-015-0013-y","volume":"1","author":"MC Gallardo","year":"2015","unstructured":"Gallardo MC, Reoyo AT, Fern\u00e1ndez-Pinero J, Iglesias I, Mu\u00f1oz MJ, Arias ML. African swine fever: a global view of the current challenge. Porcine Health Manag. 2015;1:21.","journal-title":"Porcine Health Manag"},{"key":"2070_CR7","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1136\/vr.k3774","volume":"183","author":"X Li","year":"2018","unstructured":"Li X, Tian K. African swine fever in China. Vet Rec. 2018;183:300.","journal-title":"Vet Rec"},{"key":"2070_CR8","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/tbed.13364","volume":"67","author":"T Teklue","year":"2020","unstructured":"Teklue T, Sun Y, Abid M, Luo Y, Qiu HJ. Current status and evolving approaches to African swine fever vaccine development. Transbound Emerg Dis. 2020;67:529\u201342.","journal-title":"Transbound Emerg Dis"},{"key":"2070_CR9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3390\/vaccines5040035","volume":"5","author":"M Arias","year":"2017","unstructured":"Arias M, de la Torre A, Dixon L, Gallardo C, Jori F, Laddomada A, Martins C, Parkhouse RM, Revilla Y, Rodriguez FAJ. Approaches and perspectives for development of african swine fever virus vaccines. Vaccines. 2017;5:35.","journal-title":"Vaccines"},{"key":"2070_CR10","doi-asserted-by":"publisher","first-page":"3879","DOI":"10.1016\/j.vaccine.2014.05.051","volume":"32","author":"S Blome","year":"2014","unstructured":"Blome S, Gabriel C, Beer M. Modern adjuvants do not enhance the efficacy of an inactivated African swine fever virus vaccine preparation. Vaccine. 2014;32:3879\u201382.","journal-title":"Vaccine"},{"key":"2070_CR11","doi-asserted-by":"publisher","first-page":"e323","DOI":"10.1111\/tbed.12303","volume":"63","author":"LK Mulumba-Mfumu","year":"2016","unstructured":"Mulumba-Mfumu LK, Goatley LC, Saegerman C, Takamatsu HH, Dixon LK. Immunization of african indigenous pigs with attenuated genotype I African swine fever virus OURT88\/3 induces protection against challenge with virulent strains of genotype I. Transbound Emerg Dis. 2016;63:e323-327.","journal-title":"Transbound Emerg Dis"},{"key":"2070_CR12","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1099\/0022-1317-82-3-513","volume":"82","author":"A Leit\u00e3o","year":"2001","unstructured":"Leit\u00e3o A, Cartaxeiro C, Coelho R, Cruz B, Parkhouse RME, Portugal FC, Vig\u00e1rio JD, Martins CLV. The non-haemadsorbing African swine fever virus isolate ASFV\/NH\/P68 provides a model for defining the protective anti-virus immune response. J Gen Virol. 2001;82:513\u201323.","journal-title":"J Gen Virol"},{"key":"2070_CR13","doi-asserted-by":"publisher","first-page":"e00329-22","DOI":"10.1128\/jvi.00329-22","volume":"96","author":"M Ding","year":"2022","unstructured":"Ding M, Dang W, Liu H, Xu F, Huang H, Sunkang Y, Li T, Pei J, Liu X, Zhang Y, Zheng H. Combinational Deletions of MGF360-9L and MGF505-7R Attenuated Highly Virulent African Swine Fever Virus and Conferred Protection against Homologous Challenge. J Virol. 2022;96:e00329-22.","journal-title":"J Virol"},{"key":"2070_CR14","doi-asserted-by":"publisher","first-page":"2148560","DOI":"10.1080\/22221751.2022.2148560","volume":"12","author":"Y Liu","year":"2023","unstructured":"Liu Y, Xie Z, Li Y, Song Y, Di D, Liu J, Gong L, Chen Z, Wu J, Ye Z, et al. Evaluation of an I177L gene-based five-gene-deleted African swine fever virus as a live attenuated vaccine in pigs. Emerg Microbes Infect. 2023;12:2148560.","journal-title":"Emerg Microbes Infect"},{"key":"2070_CR15","doi-asserted-by":"publisher","first-page":"4593","DOI":"10.1016\/j.vaccine.2011.04.052","volume":"29","author":"K King","year":"2011","unstructured":"King K, Chapman D, Argilaguet JM, Fishbourne E, Hutet E, Cariolet R, Hutchings G, Oura CA, Netherton CL, Moffat K, et al. Protection of European domestic pigs from virulent African isolates of African swine fever virus by experimental immunisation. Vaccine. 2011;29:4593\u2013600.","journal-title":"Vaccine"},{"key":"2070_CR16","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/vaccines7010012","volume":"7","author":"SY Sunwoo","year":"2019","unstructured":"Sunwoo SY, P\u00e9rez-N\u00fa\u00f1ez D, Morozov I, S\u00e1nchez EG, Gaudreault NN, Trujillo JD, Mur L, Nogal M, Madden D, Urbaniak K, Kim IJ. DNA-protein vaccination strategy does not protect from challenge with African swine fever virus Armenia 2007 strain. Vaccines. 2019;7:12.","journal-title":"Vaccines"},{"key":"2070_CR17","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1007\/s007050170056","volume":"146","author":"MG Barderas","year":"2001","unstructured":"Barderas MG, Rodr\u00edguez F, G\u00f3mez-Puertas P, Avil\u00e9s M, Beitia F, Alonso C, Escribano JM. Antigenic and immunogenic properties of a chimera of two immunodominant African swine fever virus proteins. Arch Virol. 2001;146:1681\u201391.","journal-title":"Arch Virol"},{"key":"2070_CR18","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1006\/viro.1998.9068","volume":"243","author":"P G\u00f3mez-Puertas","year":"1998","unstructured":"G\u00f3mez-Puertas P, Rodr\u00edguez F, Oviedo JM, Brun A, Alonso C, Escribano JM. The African swine fever virus proteins p54 and p30 are involved in two distinct steps of virus attachment and both contribute to the antibody-mediated protective immune response. Virology. 1998;243:461\u201371.","journal-title":"Virology"},{"key":"2070_CR19","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1006\/viro.1996.0193","volume":"218","author":"F Ruiz-Gonzalvo","year":"1996","unstructured":"Ruiz-Gonzalvo F, Rodr\u00edguez F, Escribano JM. Functional and immunological properties of the baculovirus-expressed hemagglutinin of African swine fever virus. Virology. 1996;218:285\u20139.","journal-title":"Virology"},{"key":"2070_CR20","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1099\/jgv.0.000490","volume":"97","author":"G Burmakina","year":"2016","unstructured":"Burmakina G, Malogolovkin A, Tulman ER, Zsak L, Delhon G, Diel DG, Shobogorov NM, Morgunov YP, Morgunov SY, Kutish GF, et al. African swine fever virus serotype-specific proteins are significant protective antigens for African swine fever. J Gen Virol. 2016;97:1670\u20135.","journal-title":"J Gen Virol"},{"key":"2070_CR21","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.virol.2003.11.011","volume":"319","author":"JG Neilan","year":"2004","unstructured":"Neilan JG, Zsak L, Lu Z, Burrage TG, Kutish GF, Rock DL. Neutralizing antibodies to African swine fever virus proteins p30, p54, and p72 are not sufficient for antibody-mediated protection. Virology. 2004;319:337\u201342.","journal-title":"Virology"},{"key":"2070_CR22","doi-asserted-by":"publisher","first-page":"13322","DOI":"10.1128\/JVI.01893-14","volume":"88","author":"A Lacasta","year":"2014","unstructured":"Lacasta A, Ballester M, Monteagudo PL, Rodr\u00edguez JM, Salas ML, Accensi F, Pina-Pedrero S, Bensaid A, Argilaguet J, L\u00f3pez-Soria S, et al. Expression library immunization can confer protection against lethal challenge with African swine fever virus. J Virol. 2014;88:13322\u201332.","journal-title":"J Virol"},{"key":"2070_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0040942","volume":"7","author":"JM Argilaguet","year":"2012","unstructured":"Argilaguet JM, P\u00e9rez-Mart\u00edn E, Nofrar\u00edas M, Gallardo C, Accensi F, Lacasta A, Mora M, Ballester M, Galindo-Cardiel I, L\u00f3pez-Soria S, et al. DNA vaccination partially protects against African swine fever virus lethal challenge in the absence of antibodies. PLoS ONE. 2012;7: e40942.","journal-title":"PLoS ONE"},{"key":"2070_CR24","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.molimm.2014.10.020","volume":"64","author":"AP Basto","year":"2015","unstructured":"Basto AP, Badenes M, Almeida SC, Martins C, Duarte A, Santos DM, Leit\u00e3o A. Immune response profile elicited by the model antigen ovalbumin expressed in fusion with the bacterial OprI lipoprotein. Mol Immunol. 2015;64:36\u201345.","journal-title":"Mol Immunol"},{"key":"2070_CR25","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.4049\/jimmunol.174.2.1097","volume":"174","author":"H Revets","year":"2005","unstructured":"Revets H, Pynaert G, Grooten J, De Baetselier P. Lipoprotein I, a TLR2\/4 ligand modulates Th2-driven allergic immune responses. J Immunol. 2005;174:1097\u2013103.","journal-title":"J Immunol"},{"key":"2070_CR26","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1128\/IAI.70.1.240-248.2002","volume":"70","author":"J Cote-Sierra","year":"2002","unstructured":"Cote-Sierra J, Bredan A, Toldos CM, Stijlemans B, Brys L, Cornelis P, Segovia M, de Baetselier P, Revets H. Bacterial lipoprotein-based vaccines induce tumor necrosis factor-dependent type 1 protective immunity against Leishmania major. Infect Immun. 2002;70:240\u20138.","journal-title":"Infect Immun"},{"key":"2070_CR27","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0166-0934(98)00105-0","volume":"75","author":"A Leit\u00e3o","year":"1998","unstructured":"Leit\u00e3o A, Malur A, Cornelis P, Martins CLV. Identification of a 25-aminoacid sequence from the major African swine fever virus structural protein VP72 recognised by porcine cytotoxic T lymphocytes using a lipoprotein based expression system. J Virol Methods. 1998;75:113\u20139.","journal-title":"J Virol Methods"},{"key":"2070_CR28","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1007\/s007050070081","volume":"145","author":"A Leit\u00e3o","year":"2000","unstructured":"Leit\u00e3o A, Malur A, Cartaxeiro C, Vasco G, Cruz B, Cornelis P, Martins CL. Bacterial lipoprotein based expression vectors as tools for the characterisation of African swine fever virus (ASFV) antigens. Arch Virol. 2000;145:1639\u201357.","journal-title":"Arch Virol"},{"key":"2070_CR29","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1016\/j.molimm.2010.04.012","volume":"47","author":"CH Leng","year":"2010","unstructured":"Leng CH, Chen HW, Chang LS, Liu HH, Liu HY, Sher YP, Chang YW, Lien SP, Huang TY, Chen MY, et al. A recombinant lipoprotein containing an unsaturated fatty acid activates NF-kappaB through the TLR2 signaling pathway and induces a differential gene profile from a synthetic lipopeptide. Mol Immunol. 2010;47:2015\u201321.","journal-title":"Mol Immunol"},{"key":"2070_CR30","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1017\/S0031182016000056","volume":"143","author":"A Aguado-Mart\u00ednez","year":"2016","unstructured":"Aguado-Mart\u00ednez A, Basto AP, M\u00fcller J, Balmer V, Manser V, Leit\u00e3o A, Hemphill A. N-terminal fusion of a toll-like receptor 2-ligand to a Neospora caninum chimeric antigen efficiently modifies the properties of the specific immune response. Parasitology. 2016;143:606\u201316.","journal-title":"Parasitology"},{"key":"2070_CR31","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.vaccine.2018.11.060","volume":"37","author":"A Aguado-Mart\u00ednez","year":"2019","unstructured":"Aguado-Mart\u00ednez A, Basto AP, Tanaka S, Ryser LT, Nunes TP, Ortega-Mora LM, Arranz-Sol\u00eds D, Leit\u00e3o A, Hemphill A. Immunization with a cocktail of antigens fused with OprI reduces Neospora caninum vertical transmission and postnatal mortality in mice. Vaccine. 2019;37:473\u201383.","journal-title":"Vaccine"},{"key":"2070_CR32","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jbiotec.2011.11.006","volume":"157","author":"AP Basto","year":"2012","unstructured":"Basto AP, Piedade J, Ramalho R, Alves S, Soares H, Cornelis P, Martins C, Leit\u00e3o A. A new cloning system based on the OprI lipoprotein for the production of recombinant bacterial cell wall-derived immunogenic formulations. J Biotechnol. 2012;157:50\u201363.","journal-title":"J Biotechnol"},{"key":"2070_CR33","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3390\/vetsci6040095","volume":"6","author":"L Li","year":"2019","unstructured":"Li L, Wu J, Liu D, Du G, Liu Y, Shang Y, Liu X. Transcriptional profiles of murine bone marrow-derived dendritic cells in response to peste des petits ruminants virus. Vet Sci. 2019;6:95.","journal-title":"Vet Sci"},{"key":"2070_CR34","doi-asserted-by":"publisher","first-page":"108251","DOI":"10.1016\/j.intimp.2021.108251","volume":"101","author":"G Zhang","year":"2021","unstructured":"Zhang G, Liu W, Gao Z, Yang S, Zhou G, Chang Y, Ma Y, Liang X, Shao J, Chang H. Antigenicity and immunogenicity of recombinant proteins comprising African swine fever virus proteins p30 and p54 fused to a cell-penetrating peptide. Int Immunopharmacol. 2021;101:108251.","journal-title":"Int Immunopharmacol"},{"key":"2070_CR35","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s11427-020-1657-9","volume":"63","author":"W Chen","year":"2020","unstructured":"Chen W, Zhao D, He X, Liu R, Wang Z, Zhang X, Li F, Shan D, Chen H, Zhang J, et al. A seven-gene-deleted African swine fever virus is safe and effective as a live attenuated vaccine in pigs. Sci China Life Sci. 2020;63:623\u201334.","journal-title":"Sci China Life Sci"},{"key":"2070_CR36","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3390\/vaccines8020234","volume":"8","author":"LC Goatley","year":"2020","unstructured":"Goatley LC, Reis AL, Portugal R, Goldswain H, Shimmon GL, Hargreaves Z, Ho CS, Montoya M, S\u00e1nchez-Cord\u00f3n PJ, Taylor G, et al. A pool of eight virally vectored African swine fever antigens protect pigs against fatal disease. Vaccines. 2020;8:234.","journal-title":"Vaccines"},{"key":"2070_CR37","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.vetmic.2019.06.006","volume":"235","author":"S Lokhandwala","year":"2019","unstructured":"Lokhandwala S, Petrovan V, Popescu L, Sangewar N, Elijah C, Stoian A, Olcha M, Ennen L, Bray J, Bishop RP, et al. Adenovirus-vectored African Swine Fever Virus antigen cocktails are immunogenic but not protective against intranasal challenge with Georgia 2007\/1 isolate. Vet Microbiol. 2019;235:10\u201320.","journal-title":"Vet Microbiol"},{"key":"2070_CR38","doi-asserted-by":"publisher","first-page":"12290","DOI":"10.1128\/JVI.01333-09","volume":"83","author":"I Rodr\u00edguez","year":"2009","unstructured":"Rodr\u00edguez I, Nogal ML, Redrejo-Rodr\u00edguez M, Bustos MJ, Salas ML. The African swine fever virus virion membrane protein pE248R is required for virus infectivity and an early postentry event. J Virol. 2009;83:12290\u2013300.","journal-title":"J Virol"},{"key":"2070_CR39","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.ijbiomac.2017.08.080","volume":"106","author":"J Kaur","year":"2018","unstructured":"Kaur J, Kumar A, Kaur J. Strategies for optimization of heterologous protein expression in E. coli: roadblocks and reinforcements. Int J Biol Macromol. 2018;106:803\u201322.","journal-title":"Int J Biol Macromol"},{"key":"2070_CR40","doi-asserted-by":"publisher","first-page":"3424","DOI":"10.4049\/jimmunol.159.7.3424","volume":"159","author":"ED Franke","year":"1997","unstructured":"Franke ED, Corradin G, Hoffman SL. Induction of protective CTL responses against the Plasmodium yoelii circumsporozoite protein by immunization with peptides. J Immunol. 1997;159:3424\u201333.","journal-title":"J Immunol"},{"key":"2070_CR41","doi-asserted-by":"publisher","first-page":"4420","DOI":"10.1016\/j.vaccine.2014.06.060","volume":"32","author":"X Wen","year":"2014","unstructured":"Wen X, Wen K, Cao D, Li G, Jones RW, Li J, Szu S, Hoshino Y, Yuan L. Inclusion of a universal tetanus toxoid CD4(+) T cell epitope P2 significantly enhanced the immunogenicity of recombinant rotavirus \u0394VP8* subunit parenteral vaccines. Vaccine. 2014;32:4420\u20137.","journal-title":"Vaccine"},{"key":"2070_CR42","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3109\/08830185.2015.1096935","volume":"35","author":"I Volovitz","year":"2016","unstructured":"Volovitz I, Melzer S, Amar S, Bocsi J, Bloch M, Efroni S, Ram Z, T\u00e1rnok A. Dendritic Cells in the Context of Human Tumors: Biology and Experimental Tools. Int Rev Immunol. 2016;35:116\u201335.","journal-title":"Int Rev Immunol"},{"key":"2070_CR43","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3390\/v9090241","volume":"9","author":"LK Dixon","year":"2017","unstructured":"Dixon LK, S\u00e1nchez-Cord\u00f3n PJ, Galindo I, Alonso C. Investigations of Pro- and Anti-Apoptotic Factors Affecting African Swine Fever Virus Replication and Pathogenesis. Viruses. 2017;9:241.","journal-title":"Viruses"},{"key":"2070_CR44","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1099\/vir.0.82857-0","volume":"88","author":"AL Reis","year":"2007","unstructured":"Reis AL, Parkhouse RME, Penedos AR, Martins C, Leit\u00e3o A. Systematic analysis of longitudinal serological responses of pigs infected experimentally with African swine fever virus. J Gen Virol. 2007;88:2426\u201334.","journal-title":"J Gen Virol"},{"key":"2070_CR45","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1099\/vir.0.81038-0","volume":"86","author":"C Oura","year":"2005","unstructured":"Oura C, Denyer M, Takamatsu H, Parkhouse R. In vivo depletion of CD8+ T lymphocytes abrogates protective immunity to African swine fever virus. J Gen Virol. 2005;86:2445\u201350.","journal-title":"J Gen Virol"},{"key":"2070_CR46","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.virusres.2012.11.009","volume":"173","author":"HH Takamatsu","year":"2013","unstructured":"Takamatsu HH, Denyer MS, Lacasta A, Stirling CM, Argilaguet JM, Netherton CL, Oura CA, Martins C, Rodr\u00edguez F. Cellular immunity in ASFV responses. Virus Res. 2013;173:110\u201321.","journal-title":"Virus Res"},{"key":"2070_CR47","doi-asserted-by":"publisher","first-page":"e1010931","DOI":"10.1371\/journal.ppat.1010931","volume":"18","author":"L Bosch-Cam\u00f3s","year":"2022","unstructured":"Bosch-Cam\u00f3s L, Alonso U, Esteve-Codina A, Chang CY, Mart\u00edn-Mur B, Accensi F, Mu\u00f1oz M, Navas MJ, Dabad M, Vidal E, et al. Cross-protection against African swine fever virus upon intranasal vaccination is associated with an adaptive-innate immune crosstalk. PLoS Pathog. 2022;18:e1010931.","journal-title":"PLoS Pathog"},{"key":"2070_CR48","doi-asserted-by":"publisher","first-page":"e0005011","DOI":"10.1371\/journal.pntd.0005011","volume":"10","author":"M Islamuddin","year":"2016","unstructured":"Islamuddin M, Chouhan G, Want MY, Ozbak HA, Hemeg HA, Afrin F. Immunotherapeutic Potential of Eugenol Emulsion in Experimental Visceral Leishmaniasis. PLoS Negl Trop Dis. 2016;10:e0005011.","journal-title":"PLoS Negl Trop Dis"},{"key":"2070_CR49","doi-asserted-by":"publisher","first-page":"5689","DOI":"10.1128\/jvi.70.8.5689-5694.1996","volume":"70","author":"P Gomez-Puertas","year":"1996","unstructured":"Gomez-Puertas P, Rodriguez F, Oviedo JM, Ramiro-Ibanez F, Ruiz-Gonzalvo F, Alonso C, Escribano JM. Neutralizing antibodies to different proteins of African swine fever virus inhibit both virus attachment and internalization. J Virol. 1996;70:5689\u201394.","journal-title":"J Virol"},{"key":"2070_CR50","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.vetimm.2018.11.018","volume":"208","author":"D P\u00e9rez-N\u00fa\u00f1ez","year":"2019","unstructured":"P\u00e9rez-N\u00fa\u00f1ez D, Sunwoo SY, S\u00e1nchez EG, Haley N, Garc\u00eda-Belmonte R, Nogal M, Morozov I, Madden D, Gaudreault NN, Mur L, et al. Evaluation of a viral DNA-protein immunization strategy against African swine fever in domestic pigs. Vet Immunol Immunopathol. 2019;208:34\u201343.","journal-title":"Vet Immunol Immunopathol"},{"key":"2070_CR51","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1006\/viro.1993.1515","volume":"196","author":"L Zsak","year":"1993","unstructured":"Zsak L, Onisk D, Afonso C, Rock D. Virulent African swine fever virus isolates are neutralized by swine immune serum and by monoclonal antibodies recognizing a 72-kDa viral protein. Virology. 1993;196:596\u2013602.","journal-title":"Virology"},{"key":"2070_CR52","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.virusres.2012.10.012","volume":"173","author":"JM Escribano","year":"2013","unstructured":"Escribano JM, Galindo I, Alonso C. Antibody-mediated neutralization of African swine fever virus: myths and facts. Virus Res. 2013;173:101\u20139.","journal-title":"Virus Res"},{"key":"2070_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1600-0684.2001.300101.x","volume":"30","author":"P Silvera","year":"2001","unstructured":"Silvera P, Wade-Evans A, Rud E, Hull R, Silvera K, Sangster R, Almond N, Stott J. Mechanisms of protection induced by live attenuated simian immunodeficiency virus: III. Viral interference and the role of CD8+ T-cells and beta-chemokines in the inhibition of virus infection of PBMCs in vitro. J Med Primatol. 2001;30:1\u201313.","journal-title":"J Med Primatol"},{"key":"2070_CR54","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1038\/nm1195-1167","volume":"1","author":"A Gallimore","year":"1995","unstructured":"Gallimore A, Cranage M, Cook N, Almond N, Bootman J, Rud E, Silvera P, Dennis M, Corcoran T, Stott J, et al. Early suppression of SIV replication by CD8+ nef-specific cytotoxic T cells in vaccinated macaques. Nat Med. 1995;1:1167\u201373.","journal-title":"Nat Med"},{"key":"2070_CR55","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12985-022-01747-9","volume":"19","author":"G Zhang","year":"2022","unstructured":"Zhang G, Liu W, Gao Z, Chang Y, Yang S, Peng Q, Ge S, Kang B, Shao J, Chang H. Antigenic and immunogenic properties of recombinant proteins consisting of two immunodominant African swine fever virus proteins fused with bacterial lipoprotein OprI. Virol J. 2022;19:16.","journal-title":"Virol J"},{"key":"2070_CR56","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3390\/vaccines7020056","volume":"7","author":"NN Gaudreault","year":"2019","unstructured":"Gaudreault NN, Richt JA. Subunit vaccine approaches for african Swine fever virus. Vaccines. 2019;7:56.","journal-title":"Vaccines"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-023-02070-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-023-02070-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-023-02070-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T17:02:12Z","timestamp":1685120532000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-023-02070-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,26]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2070"],"URL":"https:\/\/doi.org\/10.1186\/s12985-023-02070-7","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,26]]},"assertion":[{"value":"20 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experiments involving ASFV were performed within biosafety level 3 facility at the Lanzhou Veterinary Research Institute (LVRI) at the Chinese Academy of Agricultural Sciences (CAAS). Animal experiments were carried out in accordance with the regulations for the administration of affairs concerning experimental animals approved by the State Science and Technology Commission of the People\u2019s Republic of China and by the Committee for Animal Welfare and Safety in the LVRI of the CAAS (No. LVRIAEC2018-008). All animals used in this study were humanely bled during the experiments and euthanized at the end of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have agreed to publish the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"104"}}